(2S,5S,8S,11R,14R,23S)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-23-[[(2R)-2-amino-3-phenylpropanoyl]amino]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-11-(1H-indol-3-ylmethyl)-2-[(2-methyl-1H-imidazol-5-yl)methyl]-3,6,9,12,20,24-hexaoxo-1,4,7,10,1

ID: ALA427814

Max Phase: Preclinical

Molecular Formula: C57H76N16O10

Molecular Weight: 1145.34

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  Cc1nc(C[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](N)Cc3ccccc3)CCC(=O)NCCCC[C@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc3ccccc3)NC2=O)c[nH]1

Standard InChI:  InChI=1S/C57H76N16O10/c1-32(74)48(49(59)76)73-53(80)41-20-11-12-24-62-47(75)23-22-43(67-50(77)39(58)26-34-14-5-3-6-15-34)52(79)72-46(29-37-31-64-33(2)66-37)56(83)70-44(27-35-16-7-4-8-17-35)54(81)69-42(21-13-25-63-57(60)61)51(78)71-45(55(82)68-41)28-36-30-65-40-19-10-9-18-38(36)40/h3-10,14-19,30-32,39,41-46,48,65,74H,11-13,20-29,58H2,1-2H3,(H2,59,76)(H,62,75)(H,64,66)(H,67,77)(H,68,82)(H,69,81)(H,70,83)(H,71,78)(H,72,79)(H,73,80)(H4,60,61,63)/t32-,39-,41-,42+,43+,44+,45-,46+,48+/m1/s1

Standard InChI Key:  JYZUNUUQCBCNGE-IMBOPAGWSA-N

Associated Targets(Human)

MC1R Tclin Melanocortin receptor 1 (2696 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mc1r Melanocortin receptor 1 (1101 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mc3r Melanocortin receptor 3 (22 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mc5r Melanocortin receptor 5 (870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1145.34Molecular Weight (Monoisotopic): 1144.5930AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Han G, Haskell-Luevano C, Kendall L, Bonner G, Hadley ME, Cone RD, Hruby VJ..  (2004)  De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.,  47  (6): [PMID:14998337] [10.1021/jm030452x]

Source